‘The biotech giant that developed the first effective coronavirus treatment is now looking to expand its impact. Gilead Sciences CEO Daniel O'Day said Monday that the company would start testing an inhaled version of the antiviral drug remdesivir in August. Currently, the drug is given as an intravenous infusion. If remdesivir is effective when given through a nebulizer, that "could have significant implications in helping to stem the tide of the pandemic," O'Day wrote in an open letter.’
Read here (Business Insider, June 22, 2020)
Worst ever Covid variant? Omicron
John Campbell shares his findings on Omicron. View here (Youtube, Nov 27, 2021)
-
‘India's Covid caseload has risen sharply in the past few weeks. The country's been reporting more than 150,000 cases a day. In Janu...
-
‘In this crowded field of wrongness, one voice stands out. The voice of Alex Berenson: the former New York Times reporter, Yale-educated nov...
-
Last year, before the Covid-19 outbreak, ‘Google and one of the largest health-care networks in the United States are embroiled in a data-pr...